A subsidiary of Japanese-based Fujifilm Corp. plans to expand further a massive biopharmaceutical manufacturing plant in the state, even as the initial phase is not yet complete
FUJIFILM's (FUJIY) fourth-quarter performance benefits from solid momentum in Healthcare and Imaging Solutions business segments.
Is FUJIFILM (FUJIY) a great pick from the value investor's perspective right now? Read on to know more.
Fujifilm Holdings Corp. (FUJIY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
FUJIFILM (FUJIY) and Utilization of Carbon Dioxide Institute form a partnership to develop mass production technology for alanine.
FUJIFILM (FUJIY) second-quarter performance gains from strong revenue growth in Medical Systems, Electronic Materials and Imaging business segment.
FUJIFILM's (FUJIY) Q4 performance benefits from strength across the Healthcare, Materials and Imaging Solutions segments.
FUJIFILM's (FUJIY) Q3 performance benefits from strength across the Healthcare, Materials and Imaging Solutions segments.
HOLLY SPRINGS, N.C. (AP) — A subsidiary of Japanese conglomerate Fujifilm Holdings Corp. said Thursday that it will open a massive biopharmaceutical manufacturing plant in central North Carolina in 2025,...